348 related articles for article (PubMed ID: 26459200)
1. Ranolazine in Cardiac Arrhythmia.
Saad M; Mahmoud A; Elgendy IY; Richard Conti C
Clin Cardiol; 2016 Mar; 39(3):170-8. PubMed ID: 26459200
[TBL] [Abstract][Full Text] [Related]
2. Pharmacologic management of arrhythmias.
Ganjehei L; Massumi A; Nazeri A; Razavi M
Tex Heart Inst J; 2011; 38(4):344-9. PubMed ID: 21841856
[No Abstract] [Full Text] [Related]
3. Ranolazine reduces atrial fibrillatory wave frequency.
Black-Maier EW; Pokorney SD; Barnett AS; Liu P; Shrader P; Ng J; Goldberger JJ; Zareba W; Daubert JP; Grant AO; Piccini JP
Europace; 2017 Jul; 19(7):1096-1100. PubMed ID: 27756767
[TBL] [Abstract][Full Text] [Related]
4. The antiarrhythmic effects of ranolazine.
Foster NJ; Haines DE
Rev Cardiovasc Med; 2009; 10 Suppl 1():S38-45. PubMed ID: 19898287
[TBL] [Abstract][Full Text] [Related]
5. Potential application of late sodium current blockade in the treatment of heart failure and atrial fibrillation.
Doshi D; Morrow JP
Rev Cardiovasc Med; 2009; 10 Suppl 1():S46-52. PubMed ID: 19898288
[TBL] [Abstract][Full Text] [Related]
6. Is ranolazine an antiarrhythmic drug?
Eckhardt LL; Teelin TC; January CT
Am J Physiol Heart Circ Physiol; 2008 May; 294(5):H1989-91. PubMed ID: 18375723
[No Abstract] [Full Text] [Related]
7. Inhibition of Late Sodium Current as an Innovative Antiarrhythmic Strategy.
Bengel P; Ahmad S; Sossalla S
Curr Heart Fail Rep; 2017 Jun; 14(3):179-186. PubMed ID: 28455610
[TBL] [Abstract][Full Text] [Related]
8. Modulation of spiral wave reentry by K(+) channel blockade.
Honjo H; Yamazaki M; Kamiya K; Kodama I
Circ J; 2007; 71 Suppl A():A26-31. PubMed ID: 17587736
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of ranolazine's dual protection against atrial and ventricular fibrillation.
Verrier RL; Kumar K; Nieminen T; Belardinelli L
Europace; 2013 Mar; 15(3):317-24. PubMed ID: 23220484
[TBL] [Abstract][Full Text] [Related]
10. Ranolazine: an antianginal drug with antiarrhythmic properties.
Tamargo J; Caballero R; Delpón E
Expert Rev Cardiovasc Ther; 2011 Jul; 9(7):815-27. PubMed ID: 21809962
[TBL] [Abstract][Full Text] [Related]
11. Abnormalities in sodium current and calcium homoeostasis as drivers of arrhythmogenesis in hypertrophic cardiomyopathy.
Coppini R; Santini L; Olivotto I; Ackerman MJ; Cerbai E
Cardiovasc Res; 2020 Jul; 116(9):1585-1599. PubMed ID: 32365196
[TBL] [Abstract][Full Text] [Related]
12. Cardiac arrhythmogenesis: a tale of two clocks?
Lei M; Huang CL
Cardiovasc Res; 2020 Dec; 116(14):e205-e209. PubMed ID: 31800017
[No Abstract] [Full Text] [Related]
13. Ranolazine: Electrophysiologic Effect, Efficacy, and Safety in Patients with Cardiac Arrhythmias.
Shenasa M; Assadi H; Heidary S; Shenasa H
Card Electrophysiol Clin; 2016 Jun; 8(2):467-79. PubMed ID: 27261835
[TBL] [Abstract][Full Text] [Related]
14. The Relentless Pursuit of New Drugs to Treat Cardiac Arrhythmias.
Kowey PR; Robinson VM
Circulation; 2020 May; 141(19):1507-1509. PubMed ID: 32392105
[No Abstract] [Full Text] [Related]
15. The Past, Present, and Potential Future of Sodium Channel Block as an Atrial Fibrillation Suppressing Strategy.
Aguilar M; Nattel S
J Cardiovasc Pharmacol; 2015 Nov; 66(5):432-40. PubMed ID: 25923324
[TBL] [Abstract][Full Text] [Related]
16. Update on ranolazine in the management of angina.
Codolosa JN; Acharjee S; Figueredo VM
Vasc Health Risk Manag; 2014; 10():353-62. PubMed ID: 25028555
[TBL] [Abstract][Full Text] [Related]
17. Ranolazine and late cardiac sodium current--a therapeutic target for angina, arrhythmia and more?
Makielski JC; Valdivia CR
Br J Pharmacol; 2006 May; 148(1):4-6. PubMed ID: 16520741
[TBL] [Abstract][Full Text] [Related]
18. Postrepolarization refractoriness in acute ischemia and after antiarrhythmic drug administration: action potential duration is not always an index of the refractory period.
Coronel R; Janse MJ; Opthof T; Wilde AA; Taggart P
Heart Rhythm; 2012 Jun; 9(6):977-82. PubMed ID: 22293142
[TBL] [Abstract][Full Text] [Related]
19. An examination of the cardiac actions of PD117,302, a κ-opioid receptor agonist.
Pugsley MK; Saint DA; Hayes ES; Abraham S; Walker MJ
Eur J Pharmacol; 2015 Aug; 761():330-40. PubMed ID: 26086860
[TBL] [Abstract][Full Text] [Related]
20. Drug-induced post-repolarization refractoriness as an antiarrhythmic principle and its underlying mechanism.
Franz MR; Gray RA; Karasik P; Moore HJ; Singh SN
Europace; 2014 Nov; 16 Suppl 4():iv39-iv45. PubMed ID: 25362169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
